Medicus Pharma【MDCX】銘柄情報

Medicus Pharma Ltd (MDCX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

5.69

( - )

買値

3.60

売値

5.91

出来高

平均取引量 (3 か月)

$ 4,097,487

財務取引量

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

322.385M

企業価値

19.857M

前日終値

5.69

始値

時刻

最終取引時間

VWAP

歳入

純利益

-51.22M

発行済株式数

56,658,164

浮動株比率 (%)

88.85%

機関投資家保有比率 (%)

10.64%

配当利回り

PER

-0.18

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-2.37

ベータ

-0.64

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboratio... Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania. 詳細を表示

セクター

業界

ウェブサイト

medicuspharma.com

本社

West Conshohocken, United States

設立

2026

Medicus Pharma Ltd is listed in the sector of the トロントベンチャー取引所 with ticker MDCX. The last closing price for Medicus Pharma was $5.69. Over the last year, Medicus Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Medicus Pharma currently has 56,658,164 shares in issue. The market capitalisation of Medicus Pharma is $322.38 million. Medicus Pharma has a price to earnings ratio (PE ratio) of -0.18.